Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Bateman

Showing results (111-120 of 227) with videos related to

Pageof 23
Sort By:
Journal of Toxicology. Clinical Toxicology|January 1, 1985
Quinine amblyopia: is current management appropriate?E H Dyson, A T Proudfoot, D N Bateman
British Journal of Clinical Pharmacology|June 26, 1999
Clinical pharmacology and therapeutics in a changing worldD N Bateman, G T McInnes, D J Webb
European Journal of Clinical Pharmacology|January 1, 1983
The effects of astemizole on histamine-induced weal and flareD N Bateman, P H Chapman, M D Rawlins
Lancet (London, England)|November 19, 1988
Prochlorperazine and the elderlyD N Bateman, M D Rawlins, K W Woodhouse
Emergency Medicine Journal : EMJ|September 24, 2009
The use of atropine in a nerve agent response with specific reference to children: are current guidelines too cautious?E A Sandilands, A M Good, D N Bateman
Statistics in Medicine|October 1, 1987
Using the Adverse Reactions Register to study the effects of age and sex on adverse drug reactionsJ M Simpson, D N Bateman, M D Rawlins
British Journal of Clinical Pharmacology|November 1, 1992
Attitudes to adverse drug reaction reporting in the Northern RegionD N Bateman, G L Sanders, M D Rawlins
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|January 1, 1997
Prescribing behaviour in general practice: the impact of promoting therapeutically equivalent cheaper medicinesS J Roberts, D N Bateman, J M Smith
Human Toxicology|October 1, 1984
Adverse reactions to N-acetylcysteineD N Bateman, K W Woodhouse, M D Rawlins
Therapeutic Drug Monitoring|January 1, 1980
Therapeutic drug monitoring: antihypertensive agentsD N Bateman, G L Sanders, M D Rawlins
Pageof 23

Showing results (111-120 of 227) with videos related to

Sort By:
Pageof 23
Journal of Toxicology. Clinical Toxicology|January 1, 1985
Quinine amblyopia: is current management appropriate?E H Dyson, A T Proudfoot, D N Bateman
British Journal of Clinical Pharmacology|June 26, 1999
Clinical pharmacology and therapeutics in a changing worldD N Bateman, G T McInnes, D J Webb
European Journal of Clinical Pharmacology|January 1, 1983
The effects of astemizole on histamine-induced weal and flareD N Bateman, P H Chapman, M D Rawlins
Lancet (London, England)|November 19, 1988
Prochlorperazine and the elderlyD N Bateman, M D Rawlins, K W Woodhouse
Emergency Medicine Journal : EMJ|September 24, 2009
The use of atropine in a nerve agent response with specific reference to children: are current guidelines too cautious?E A Sandilands, A M Good, D N Bateman
Statistics in Medicine|October 1, 1987
Using the Adverse Reactions Register to study the effects of age and sex on adverse drug reactionsJ M Simpson, D N Bateman, M D Rawlins
British Journal of Clinical Pharmacology|November 1, 1992
Attitudes to adverse drug reaction reporting in the Northern RegionD N Bateman, G L Sanders, M D Rawlins
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|January 1, 1997
Prescribing behaviour in general practice: the impact of promoting therapeutically equivalent cheaper medicinesS J Roberts, D N Bateman, J M Smith
Human Toxicology|October 1, 1984
Adverse reactions to N-acetylcysteineD N Bateman, K W Woodhouse, M D Rawlins
Therapeutic Drug Monitoring|January 1, 1980
Therapeutic drug monitoring: antihypertensive agentsD N Bateman, G L Sanders, M D Rawlins
Pageof 23